Study of the Safety of Intravenous Artesunate

NCT00292942 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

FED

Sponsor class

Conditions

Malaria
Malaria, Cerebral

Interventions

DRUG: Intravenous Artesunate
DRUG: Placebo

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]